TL;DR: For a limited time, get permanent access to the PDF Converter & Editor for just $29.99 (MSRP $99.99). Here’s a solid way to simplify your workflow: for a limited time, you can get lifetime ...
In a Phase 1, first-in-human trial, a one-time infusion of an investigational CRISPR-Cas9 therapy targeting angiopoietin-like protein 3 (ANGPTL3) was safe and reduced LDL cholesterol by nearly 50% and ...
The trial, Left Atrial Appendage CLOSURE in Patients with Atrial Fibrillation at High Risk of Stroke and Bleeding Compared to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback